CTRI/2014/01/004282招募中3 期
Clinical study on Garpa vaayu (polycystic ovarian disease) and the drug of choice is Soothaga vaayu leghium and Veezhi ennei.
AYOTHIDOSS PANDITHAR HOSPITA0 个研究点目标入组 40 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Age: 16-35 years
- •Patient having the symptoms of irregular menstruation
- •Oligomenorrhoea (or) Amenorrhoea (or) Dysmenorrhoea
- •Patient willing to take USG pelvis
- •Patient willing to undergo routine blood investigation.
- •USG pelvis showing polycystic ovaries
- •Patient willing to undergo purgation as a preparatory part of treatment
- •Patient willing to participate in trial and signing in consent form
排除标准
- •H/O hypertension
- •H/O diabetes mellitus
- •H/O cardiac disease
- •Pregnancy and lactation
- •H/O thyroid dysfunction
- •H/O recent hormone therapy (Past one year)
研究者
相似试验
进行中（未招募）
不适用
Effects of physical exercise on cholesterol, glycemia and menstrual cycle of women with micropolicistos in the ovaryRBR-6nhy6hDepartamento de Toco-Ginecologia da Universidade Federal do Rio Grande do Norte
尚未招募
不适用
Effect of unani medicine in the treatment of Polycystic Ovarian disease. An open Observational studyCTRI/2021/02/031070ational Institute of Unani Medicine
已完成
不适用
Follow-up study of patients with polycystic ovary syndrome for predicting risk factors of cardiovascular diseaseEndocrine, nutritional and metabolic diseaseKCT0000739Korea Centers for Disease Control and Prevention200
尚未招募
2 期
Benefits of Sharbat Afsanteen in Poly Cystic Ovarian DiseaseCTRI/2019/03/017970ational Institute of Unani Medicine
尚未招募
1 期
Clinical study on improving ovarian function of women with perimenopausal syndrome by Zishui Qinggan Lichong DecoctioPerimenopausal syndromeITMCTR2000002899The Third Affiliated Hospital of Beijing University of Chinese Medicine